Rapid improvement of life-threatening capillary leak syndrome after stem cell transplantation by bevacizumab

Blood. 2010 Apr 1;115(13):2723-4. doi: 10.1182/blood-2009-11-247056.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Bone Marrow Transplantation / adverse effects*
  • Capillary Leak Syndrome / drug therapy*
  • Capillary Leak Syndrome / etiology
  • Child
  • Graft vs Host Disease / etiology
  • Humans
  • Male
  • Pleural Effusion / drug therapy
  • Pleural Effusion / etiology
  • Posterior Leukoencephalopathy Syndrome / drug therapy*
  • Posterior Leukoencephalopathy Syndrome / etiology
  • Remission Induction
  • Transplantation, Homologous
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab